Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Climb Bio, Inc. | Director | Common Stock | 179K | $235K | $1.31 | Mar 27, 2025 | Direct |
Climb Bio, Inc. | Director | Restricted Stock Units | 25.1K | $32.9K | $1.31 | Mar 27, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLYM | Climb Bio, Inc. | Mar 27, 2025 | 2 | $0 | 4 | Mar 27, 2025 | Director |
CLYM | Climb Bio, Inc. | Jan 1, 2025 | 2 | $0 | 4 | Jan 3, 2025 | Director |
ELYM | Eliem Therapeutics, Inc. | Jun 27, 2024 | 2 | $0 | 4 | Jun 27, 2024 | Director |
ELYM | Eliem Therapeutics, Inc. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | Director |